GLP-1 and Teeth: Enamel Erosion & Dry Mouth (2026)

“Ozempic teeth” is not a clinical diagnosis — you won't find it in a dental textbook. It's a label that spread through patient forums and social media before dentists started using it, describing a cluster of problems some people notice after starting a GLP-1: dry mouth, new sensitivity, faster decay, and visible enamel erosion. The important thing to understand is the mechanism. Semaglutide and other GLP-1 drugs are not corrosive and do not bind to or dissolve enamel. The harm, when it happens, is indirect: two of the most common side effects — nausea/vomiting and dry mouth (xerostomia) — change the chemistry of your mouth in ways that can erode enamel and accelerate cavities (Barać 2025^[3]; Kofman 2026^[4]). There is no large GLP-1-specific dental trial, so this article extrapolates from decades of well-established acid-erosion and dry-mouth dentistry, and lays out the simple protective steps that actually matter. For the gum-disease side of GLP-1 oral health, see GLP-1 and dental health: periodontitis and xerostomia.

The honest summary

• GLP-1 drugs don't attack enamel directly. Semaglutide is not corrosive. “Ozempic teeth” is a media/patient label, not a diagnosis — the damage is driven by side effects, not the molecule touching your teeth (Barać 2025^[3]; Kofman 2026^[4]).
• Vomiting is the erosion risk. Stomach acid is highly acidic (roughly pH 1.5–3.5), well below the ~5.5 threshold at which enamel begins to demineralize. Repeated vomiting bathes the inside surfaces of teeth in acid — the same mechanism that erodes teeth in reflux and in eating disorders, where erosion is markedly more common (Hermont 2014^[6]).
• Vomiting is common early on. In the STEP 1 trial of semaglutide 2.4 mg, vomiting affected about 24% of participants versus ~6% on placebo, and nausea about 44% — mostly during dose escalation (Wilding 2021^[1]).
• Dry mouth removes your natural defense. Saliva buffers acid, washes away food, and delivers calcium, phosphate, and fluoride that remineralize enamel. GLP-1-associated reduced fluid intake and hyposalivation lower that protection, raising cavity (caries) risk (Mawardi 2023^[2]; Barać 2025^[3]).
• Eating and drinking less compounds it. Appetite suppression can mean less chewing-stimulated saliva and, for some, more frequent sips of acidic or sugary “rescue” drinks — both unhelpful for teeth.
• It's largely preventable, and not all permanent. Dry mouth and decay risk respond to hydration, fluoride, and good routine. But enamel does not grow back — erosion already lost is permanent, so prevention is the whole game (Mahoney 2003^[9]).
• One counter-intuitive rule: do NOT brush right after vomiting. Acid temporarily softens enamel; brushing immediately scrubs away the softened layer. Rinse first, wait, then brush (Attanasi 2025^[7]; Ganss 2007^[8]).

Why "Ozempic teeth" is about acid and saliva, not the drug

Enamel is the hardest tissue in the body, but it has one weakness: acid. When the pH at the tooth surface drops below roughly 5.5, enamel starts to lose mineral — a process called demineralization. Normally your saliva fixes this within minutes by neutralizing the acid and re-depositing calcium and phosphate. Problems arise when acid exposure is frequent or saliva is scarce. GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide and others) don't touch enamel themselves, but their two signature side effects hit both of those levers at once (Barać 2025^[3]).

The acid lever is vomiting. Gastric contents are roughly pH 1.5–3.5 — far below the demineralization threshold. When someone vomits, that acid washes over the teeth, preferentially the tongue-facing and biting surfaces. This is the identical mechanism that produces the well-documented erosion seen in gastroesophageal reflux and in eating disorders involving self-induced vomiting. A systematic review and meta-analysis found people with eating disorders had substantially higher odds of dental erosion than those without (Hermont 2014^[6]), and reflux-driven erosive tooth wear is a recognized clinical entity with a standard interdisciplinary management approach (Attanasi 2025^[7]). GLP-1 vomiting is usually transient — concentrated in the first weeks after starting or after each dose increase — but in the STEP 1 trial about one in four people on semaglutide 2.4 mg vomited at some point, and nausea was reported by roughly 44% (Wilding 2021^[1]). For most that's occasional; for a minority it's frequent enough to matter for the teeth.

The saliva lever is dry mouth. Saliva is the mouth's buffering, cleansing, and remineralizing system. Reduce it and acids linger longer, sugars aren't cleared, and enamel can't repair between meals — which is why hyposalivation is a classic driver of rapid, widespread caries. GLP-1 users report dry mouth through two routes: reduced fluid and food intake (less chewing, less drinking, less salivary stimulation) and, in some cases, apparent direct effects on salivary flow. A published case series specifically documented semaglutide-associated hyposalivation (Mawardi 2023^[2]), and narrative reviews of GLP-1 and oral health treat xerostomia as one of the main plausible pathways to dental harm (Barać 2025^[3]; Kofman 2026^[4]).

How strong is the evidence, honestly?

It is important to be candid: there is no large randomized trial measuring tooth erosion or cavities as an endpoint in GLP-1 users. What exists is (1) robust, decades-old dentistry showing that acid exposure erodes enamel and that low saliva drives caries; (2) trial adverse-event data confirming that vomiting and nausea are common on these drugs (Wilding 2021^[1]); (3) case reports and case series of GLP-1-associated hyposalivation (Mawardi 2023^[2]); and (4) narrative reviews and emerging dental-management guidance that connect those dots (Barać 2025^[3]; Kofman 2026^[4]; Motamedi 2026^[5]). So the mechanism is on very firm ground, and the side-effect frequencies are well measured, but the population-level dental impact of GLP-1 therapy has not been quantified in controlled studies. That cuts both ways: it means the “Ozempic teeth” headlines outrun the data, but it also means the prudent move is straightforward prevention rather than waiting for an RCT.

Protecting your teeth on a GLP-1 — what actually helps

If you vomit: the single most important rule

• Do NOT brush immediately after vomiting. Acid temporarily softens the enamel surface; brushing right away mechanically wears the softened layer away, making erosion worse. In situ studies of eroded enamel show that waiting before brushing — and using fluoride — reduces this abrasion (Ganss 2007^[8]). Reflux/erosion management guidance gives the same advice (Attanasi 2025^[7]).
• Rinse first. Immediately after vomiting, swish with plain water or, better, a teaspoon of baking soda (sodium bicarbonate) in a glass of water to neutralize acid. A fluoride mouth rinse afterward helps too.
• Then wait, then brush. Give saliva time to re-harden the enamel — commonly advised as at least 30–60 minutes — before brushing with a fluoride toothpaste and a soft brush.
• Tell your prescriber if vomiting is frequent. Persistent vomiting isn't just a dental issue — it can mean the dose is escalating too fast or that you're getting dehydrated. See the practical GLP-1 nausea management guide.

If your mouth is dry

• Hydrate deliberately. Sip water through the day. Reduced thirst and intake are part of why GLP-1 users get dry — you may need to drink on a schedule rather than waiting to feel thirsty.
• Stimulate saliva. Sugar-free gum or lozenges (look for xylitol) and avoiding mouth-drying habits help. Over-the-counter dry-mouth rinses, sprays, or gels are options your dentist can recommend.
• Avoid the trap of acidic/sugary rescue drinks. Many people fight nausea or dry mouth with sodas, sports drinks, citrus, or frequent sweet sips — all of which feed both erosion and decay. Choose water, and if you do have something acidic, have it with a meal rather than grazing on it.
• Maximize fluoride. Brush twice daily with a fluoride toothpaste; your dentist may prescribe a high-fluoride toothpaste or in-office fluoride varnish, which is a standard caries-prevention measure when saliva is low.

Routine and dentist

• Tell your dentist you're on a GLP-1. It changes their risk assessment and lets them watch for early erosion and dry-mouth decay before it's visible to you. Emerging dental guidance for these medications now exists (Kofman 2026^[4]).
• Don't skip cleanings. Early erosion and incipient cavities are far easier to manage caught early; enamel that's already gone does not regenerate (Mahoney 2003^[9]).
• Don't stop your medication over tooth worries on your own. The dental risks are manageable with the steps above; the metabolic benefits of the drug are substantial. If side effects are severe, that's a conversation with your prescriber about dose, not a reason to quit unsupervised.

Bottom line

“Ozempic teeth” is a real phenomenon with an overstated name. GLP-1 drugs don't corrode enamel — but two of their most common side effects do the damage indirectly: vomiting bathes teeth in stomach acid (the same mechanism behind reflux and eating-disorder erosion), and dry mouth strips away saliva's natural buffering and remineralizing protection, raising cavity risk (Wilding 2021^[1]; Mawardi 2023^[2]; Barać 2025^[3]; Hermont 2014^[6]). There's no GLP-1-specific dental RCT, so this is extrapolated from well-established acid-erosion and xerostomia dentistry — but the mechanism is solid and the prevention is simple: stay hydrated, maximize fluoride, manage nausea, and above all rinse rather than brush right after vomiting, then wait before brushing (Attanasi 2025^[7]; Ganss 2007^[8]). Tell your dentist you're on a GLP-1, and don't stop the medication over tooth worries without talking to your prescriber.

This article is educational and is not medical or dental advice. Because no large clinical trial has measured tooth erosion or cavities as an outcome in GLP-1 users, the dental risks here are extrapolated from established acid-erosion and dry-mouth (xerostomia) dentistry, combined with trial-documented side-effect rates and published case series. Every claim is sourced to a peer-reviewed study or review indexed in PubMed and verified against the live PubMed database before publication. Coordinate your own care with your prescriber and dentist.